A Phase I Study of FLX925, a Dual FLT3 and CDK4/6 Inhibitor in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

• DOI: 10.1182/blood.v130.suppl_1.1343.1343
• Publication Date: 2017-12-07
• Authors: Naval Daver; Daniel A. Pollyea; David A. Rizzieri; Jeanne Palmer; Raajit K. Rampal; Shira Dinner; Dale L. Bixby; Mary‐Elizabeth M....; Tibor Kovacsovics; Kebede H. Begna; Alexander E. Perl; Marina Konopleva; Lisa Seitz; Jenny McKinnell; D. T. Johnson; William Ho; Jorge E. Cortés
• Keywords: Refractory (planetary science)